• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Methyl 5-(pyrimidin-5-yl)nicotinate: A Comprehensive Overview

Methyl 5-(pyrimidin-5-yl)nicotinate, also known by its CAS number 893740-21-1, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of nicotinates, which are derivatives of nicotinic acid, and it incorporates a pyrimidine ring, making it a unique structure with potential applications in drug design and development. The methyl ester group attached to the nicotinate moiety adds to its chemical versatility, offering opportunities for further functionalization and exploration in various research domains.

The synthesis of Methyl 5-(pyrimidin-5-yl)nicotinate involves a combination of organic synthesis techniques, including nucleophilic substitution, condensation reactions, and esterification. Recent advancements in catalytic methods have enabled more efficient and selective pathways for its preparation. For instance, the use of transition metal catalysts has been reported to enhance the yield and purity of the compound during the coupling reaction steps. These improvements are crucial for scaling up production, especially for preclinical studies where large quantities of the compound are required.

One of the most intriguing aspects of Methyl 5-(pyrimidin-5-yl)nicotinate is its pharmacological profile. Studies have shown that this compound exhibits modulatory effects on various cellular pathways, particularly those involving nicotinic acetylcholine receptors (nAChRs). The presence of the pyrimidine ring introduces steric and electronic properties that may influence receptor binding affinity and selectivity. Recent research has focused on understanding how these structural features translate into biological activity, with implications for the treatment of neurological disorders such as Alzheimer's disease and nicotine addiction.

Moreover, Methyl 5-(pyrimidin-5-yl)nicotinate has been explored as a potential lead compound in drug discovery programs targeting cancer therapy. Its ability to modulate key enzymes involved in cell proliferation and apoptosis has been documented in several preclinical models. For example, studies using human cancer cell lines have demonstrated that this compound can induce cell cycle arrest and apoptosis through mechanisms involving the activation of caspase pathways. These findings underscore its potential as a chemotherapeutic agent or as a component in combination therapies.

In addition to its pharmacological applications, Methyl 5-(pyrimidin-5-yl)nicotinate has garnered attention in materials science due to its structural similarity to molecules used in organic electronics. The pyrimidine ring contributes to aromaticity and conjugation, properties that are desirable in semiconducting materials. Researchers have investigated its ability to form self-assembled monolayers and its compatibility with various substrate materials. These studies aim to exploit its electronic properties for applications in flexible electronics and optoelectronic devices.

From an environmental standpoint, understanding the fate and toxicity of Methyl 5-(pyrimidin-5-yl)nicotinate is essential for its safe handling and disposal. Recent eco-toxicological assessments have evaluated its potential impact on aquatic organisms, with results indicating low acute toxicity under standard test conditions. However, further studies are needed to assess long-term effects and bioaccumulation potential, particularly as this compound may find broader applications in pharmaceuticals and agrochemicals.

Looking ahead, the development of novel analogs of Methyl 5-(pyrimidin-5-yl)nicotinate is expected to expand its utility across multiple disciplines. Chemists are actively exploring substitutions at various positions on both the pyrimidine ring and the nicotinate moiety to optimize pharmacokinetic properties such as bioavailability and metabolic stability. Computational modeling techniques are being employed to predict structure-activity relationships (SAR), enabling rational design strategies for improved compounds.

In conclusion, Methyl 5-(pyrimidin-5-yl)nicotinate (CAS No: 893740-21-1) stands at the intersection of chemistry, pharmacology, and materials science. Its unique structure offers diverse opportunities for research and development across multiple industries. As ongoing studies continue to unravel its full potential, this compound is poised to make significant contributions to both scientific advancement and practical applications.

• 893740-59-5(5-(Pyrimidin-5-yl)nicotinic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)